The Cooper Companies, Inc. Common Stock
COOThe Cooper Companies, Inc. (COO) is a global medical device company that specializes in designing, manufacturing, and marketing healthcare products, primarily in the fields of vision correction and women's health. The company's vision segment offers contact lenses and related products, including brands like CooperVision, while its women’s health segment develops and distributes medical devices for the treatment of gynecological conditions. Founded in 1979 and headquartered in Pleasanton, California, Cooper Companies is known for its innovation and focus on patient healthcare solutions.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 11, 2023 | $0.03 | 2023-07-26 | 2023-07-27 |
| February 10, 2023 | $0.03 | 2023-01-20 | 2023-01-23 |
| August 11, 2022 | $0.03 | 2022-07-26 | 2022-07-27 |
| February 9, 2022 | $0.03 | 2022-01-20 | 2022-01-21 |
| August 11, 2021 | $0.03 | 2021-07-26 | 2021-07-27 |
Dividends Summary
- Consistent Payer: The Cooper Companies, Inc. Common Stock has rewarded shareholders with 40 dividend payments over the past 19 years.
- Total Returned Value: Investors who held COO shares during this period received a total of $1.20 per share in dividend income.
- Latest Payout: The most recent dividend of $0.03/share was paid 896 days ago, on August 11, 2023.
- Dividend Growth: Since 2004, the dividend payout has grown by 0.0%, from $0.03 to $0.03.
- Dividend Reliability: COO has maintained or increased its dividend for 40 consecutive payments.
Company News
The global contact lens market is projected to grow from USD 18.88 billion in 2025 to USD 26.64 billion by 2033, expanding at a CAGR of 4.42%. Growth is driven by rising myopia prevalence, increasing adoption of disposable lenses, and technological advancements in silicone hydrogel materials. However, risks from eye infections and user discomfort...
A Georgia federal judge denied Teva Pharmaceutical's request to delay the first trial in approximately 3,800 lawsuits alleging its Paragard copper IUD can fracture during removal. The trial is scheduled to proceed on January 20. The judge previously expressed concerns about Teva's five-year delay in complying with an FDA mandate to update warning...
CooperCompanies announced the appointment of Walt M Rosebrough, Jr., former CEO of STERIS, as an independent director effective January 3, 2026, following a cooperation agreement with activist investor Browning West. Rosebrough will join the Corporate Governance & Nominating Committee with consideration for Board Chair by end of 2026. The company...
Cooper Companies reported strong Q4 earnings, beating expectations, and announced a portfolio review to unlock long-term value. The company expects positive organic growth and raised fiscal 2026 guidance.
U.S. stock futures recovered early losses ahead of the Federal Reserve's PCE inflation data. Netflix announced an $82.7 billion deal to acquire Warner Bros Discovery, while job cuts fell 53% month-over-month in November. Markets anticipate potential interest rate cuts in December.
